Related references
Note: Only part of the references are listed.Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia
Seung Hwan Shin et al.
BONE MARROW TRANSPLANTATION (2020)
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50 Years or Older with Severe Aplastic Anemia
Carmel Rice et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study
Krista Vaht et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan
Qamar Un Nisa Chaudhry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
Nelli Bejanyan et al.
BLOOD ADVANCES (2019)
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
George E. Georges et al.
BLOOD ADVANCES (2018)
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate
Sung-Soo Park et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Guidelines for the diagnosis and management of adult aplastic anaemia
Sally B. Killick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
Yoshiko Atsuta
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party
Raynier Devillier et al.
HAEMATOLOGICA (2016)
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party
Raynier Devillier et al.
HAEMATOLOGICA (2016)
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia
Yoshihiro Inamoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Shernan G. Holtan et al.
BLOOD (2015)
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
Andrea Bacigalupo et al.
HAEMATOLOGICA (2015)
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
Andrea Bacigalupo et al.
HAEMATOLOGICA (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups
Andrea Bacigalupo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E. D. Flowers et al.
BLOOD (2011)
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia
Mary Eapen et al.
BLOOD (2011)
The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk
Yasuhito Nannya et al.
TRANSPLANT INTERNATIONAL (2011)
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party
Andrea Bacigalupo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Tacrolimus/Methotrexate versus Cyclosporine/Methotrexate as Graft-versus-Host Disease Prophylaxis in Patients with Severe Aplastic Anemia Who Received Bone Marrow Transplantation from Unrelated Donors: Results of Matched Pair Analysis
Hiroshi Yagasaki et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia
R. Viollier et al.
BONE MARROW TRANSPLANTATION (2008)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
Hubert Schrezenmeier et al.
BLOOD (2007)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
Richard E. Champlin et al.
BLOOD (2007)
Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program
S Kojima et al.
BLOOD (2002)
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
A Hiraoka et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
